Daily Brief India: Eternal, Knowledge Realty Trust, Symbiotec Pharmalab, Nobel Hygiene Limited, Mazagon Dock Shipbuilders , MV Electrosystems, Aequs, HY Tech Engineer, Jio Platforms Ltd and more

• Blinkit’s spinoff and independent IPO is highly plausible but structurally delayed. While the quick-commerce business is now self-sustaining and adjusted EBITDA positive (₹102 crore in Q1 FY27), any near-term transaction is gated by Indian tax neutral demerger rules and the transfer of ₹1,800 crore in IND AS 116 lease liabilities rather than traditional debt covenants, as the parent holds ₹18,288 crore in cash and zero long-term debt.
• The ongoing CCI antitrust investigation on price parity and exclusivity represents the single largest threat to Eternal’s margins. If price-parity restrictions are fully dismantled, a projected 10% volume diversion to direct-to-consumer restaurant channels would directly hit the high-margin food delivery segment, threatening ₹150 crore to ₹180 crore in annualized adjusted EBITDA.
• Management incentives remain structurally detached from traditional return on capital metrics (ROIC), focusing almost exclusively on Net Order Value (NOV) scale and market capitalization milestones. This volume-first mindset is financially disciplined by a highly centralized finance bench under CFO Akshant Goyal, which has a proven track record of rapidly cutting non-performing experiments and reallocating underutilized physical infrastructure to asset-light initiatives.

• KRT posted 15% YoY revenue and NOI growth in Q1 FY27, with a record INR7,516mn distribution (DPU INR1.70), up 5% QOQ, and committed occupancy rising to 93%.
• Beneath a headline 93% committed occupancy sits 87-88% economic occupancy, a 5% gap management expects to narrow to a normalized 3% by Q4 FY27.
• A 25% mark-to-market opportunity, sub-18% LTV, and multiple organic and inorganic growth levers support a credible multi-year compounding story.

• Symbiotec Pharmalab is launching a INR 1,757 crore IPO, offering specialised pharmaceutical APIs, nutritional ingredients and complex injectable products.
• The company has built a global presence in corticosteroid and steroid hormone APIs, with a significant share of revenue coming from international markets.
• The IPO provides public investors access to a niche pharmaceutical manufacturing platform, but earnings sustainability depends on managing product concentration, regulatory compliance and global demand cycles.

• Nobel Hygiene Limited (0759062D IN) (Nobel) plans to raise around US$300m in its upcoming India IPO. The deal will be run by ICICI, IIFL and Motilal Oswal.
• Nobel Hygiene is a manufacturer of absorbent hygiene products, primarily spanning adult and baby hygiene products, including diapers and related products.
• It was India’s largest home-grown branded manufacturer of absorbent hygiene products in value terms in FY26, as per Redseer report.

• Adult diapers are the structural margin anchor, but market penetration remains extremely low (under 3% in India) due to deep-rooted social stigma, necessitating continuous high spending on awareness campaigns that cap short-term margin expansion.
• The baby diaper segment (Teddyy, Snuggy) remains a hyper-competitive, low-margin bloodbath where Nobel struggles to build brand equity against dominant MNCs like Unicharm, resulting in high customer churn and poor unit economics.
• The recently filed DRHP highlights a major strategic pivot toward balance sheet deleveraging and brownfield expansion, but the relatively small size of the primary issue (₹150 crore) raises concerns that the IPO is primarily a liquidity event for PE backers rather than a massive growth capital injection.

• Mazagon Dock has completed a strong execution phase with successful delivery of destroyers, frigates and submarines while maintaining a zero-debt balance sheet.
• The company’s existing order book provides near-term visibility, but long-term growth will depend on converting the large defence opportunity pipeline into new orders.
• Future programmes in submarines, naval combat vessels, Coast Guard platforms and international maritime opportunities can become the next growth drivers.

• MV Electrosystems has moved from railway electrical products into indigenous IGBT-based propulsion systems after completing validation and receiving commercial clearance.
• The company has a large executable propulsion order book and is entering a segment where technology qualification creates entry barriers.
• The near-term focus shifts from technology development to execution — manufacturing ramp-up, working capital management and delivery of existing orders.

• Vertically Integrated Precision Manufacturing Moat: Aequs Ltd. is an Indian contract manufacturer operating a fully integrated aerospace ecosystem within a Special Economic Zone (SEZ) in Belagavi, coupled with dedicated consumer manufacturing clusters in Koppal and Hubballi. The company provides end-to-end solutions spanning precision forging, multi-axis CNC machining, surface treatment, and complex aero-structure assemblies for global tier-1 aerospace OEMs including Airbus, Boeing, Safran, and Collins Aerospace.
• Strong Revenue Expansion vs. Operational Margin Pressures: Top-line revenue increased by 33.1% in FY2026 to INR 12,304.36M (up from INR 9,246.06M in FY2025 and INR 9,650.74M in FY2024), propelled by commercial aviation build-rate recoveries and consumer segment volume growth. However, gross margins compressed to 5.19% and EBITDA margin fell to 7.52%, leading to a widened net loss of INR -1,132.50M due to upfront investments, new facility gestation costs, and high depreciation.
• Capital-Intensive Gestation and Valuation Premium: Aequs trades at a Price-to-Book (P/B) multiple of 11.7x, comparable to high-growth precision engineering peers such as Azad Engineering (12.2x) and Unimech Aerospace (10.2x). While multi-year OEM contract visibility and the ‘China+1’ supply chain shift offer substantial long-term optionality, persistent negative Free Cash Flow to Equity (INR -5,077.93M in FY2026) necessitates disciplined capital allocation and rapid operational breakeven across non-aerospace verticals.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Hy-Tech Engineers has launched its INR 135.73 crores IPO to raise capital through a fresh issue and offer for sale. The company manufactures hydraulic fittings used across industrial applications.
• The company operates in a niche engineering segment where reliability, customization capabilities and long-standing customer relationships are important competitive factors.
• The IPO provides an opportunity to evaluate a specialized manufacturing business, while investors need to balance growth potential with customer concentration, cyclicality and valuation considerations.

• Jio Platforms is looking to raise up to US$3.75bn in its upcoming India IPO.
• Jio Platforms Ltd (JPL) is a technology and digital services platform company promoted by Reliance Industries, built on a proprietary digital technology stack and pan-India connectivity infrastructure.
• We have looked at the company’s past performance and other deal dynamics in our previous note. In this note, we undertake a peer comparison.